ZYLMD Stock Chart & Stats
$1.00
$0.00(0.00%)
At close: 4:00 PM EDT
$1.00
$0.00(0.00%)
Day’s Range― - ―
52-Week Range$0.45 - $8.82
Previous CloseN/A
Volume44.00
Average Volume (3M)769.43K
Market Cap
$286.79K
Enterprise Value$485.42K
Total Cash (Recent Filing)$25.13K
Total Debt (Recent Filing)$10.55K
Price to Earnings (P/E)―
Beta0.30
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding637,681
10 Day Avg. Volume852,726
30 Day Avg. Volume769,432
Financial Highlights & Ratios
PEG Ratio-1.82
Price to Book (P/B)0.63
Price to Sales (P/S)0.66
P/FCF Ratio1.26
Enterprise Value/Market Cap1.69
Enterprise Value/Revenue0.84
Enterprise Value/Gross Profit1.00
Enterprise Value/Ebitda39.52
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
ZYLMD FAQ
What was Central Asia Lumeichun Biotechnology’s price range in the past 12 months?
Central Asia Lumeichun Biotechnology lowest stock price was $0.45 and its highest was $8.82 in the past 12 months.
What is Central Asia Lumeichun Biotechnology’s market cap?
Central Asia Lumeichun Biotechnology’s market cap is $286.79K.
When is Central Asia Lumeichun Biotechnology’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Central Asia Lumeichun Biotechnology’s earnings last quarter?
Currently, no data Available
Is Central Asia Lumeichun Biotechnology overvalued?
According to Wall Street analysts Central Asia Lumeichun Biotechnology’s price is currently Overvalued.
Does Central Asia Lumeichun Biotechnology pay dividends?
Central Asia Lumeichun Biotechnology does not currently pay dividends.
What is Central Asia Lumeichun Biotechnology’s EPS estimate?
Central Asia Lumeichun Biotechnology’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Central Asia Lumeichun Biotechnology have?
Central Asia Lumeichun Biotechnology has 637,681 shares outstanding.
What happened to Central Asia Lumeichun Biotechnology’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Central Asia Lumeichun Biotechnology?
Currently, no hedge funds are holding shares in ZYLMD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Central Asia Lumeichun Biotechnology
TOCCA Life Holdings, Inc. operates sober living facilities in Lake Worth, Lantana, and Boynton Beach, Florida. The company provides clinical toxicology testing services to monitor the illicit drug use and transforms sobriety addicted clients and the community into productive members of society. It offers sober support services; operates an addiction treatment center; provides sober life coaching and transitional living programs; conducts sports events and fitness activities; and operates house recovery residence facilities and sober living recovery residences. It offers equipment, materials, and demonstrations in the areas of cooking, cleaning, household maintenance, business etiquette, basic math, basic banking, computer skills, writing skills, life coaching, transitional living management, graphic art, information technology, marketing, television production, interest rate theories, credit cost valuation, mortgage banking, career opportunities, business models, business infrastructures, business ethics, and entrepreneurship. It also offers prepaid services, which include hygiene, linen, grocery, and other products and services online. The company was formerly known as TOCCA Life Coaching, Inc. and changed its name to TOCCA Life Holdings, Inc. in January 2015. TOCCA Life Holdings, Inc. was founded in 2013 and is based in Lake Worth, Florida.